Virginia Retirement Systems’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$748K Sell
89,337
-4,700
-5% -$42.8K ﹤0.01% 841
2026
Q1
$847K Buy
94,037
+19,600
+26% +$309K 0.01% 640
2025
Q4
$1.36M Sell
74,437
-1,000
-1% -$16.9K 0.01% 502
2025
Q3
$1.11M Sell
75,437
-14,100
-16% -$242K 0.01% 575
2025
Q2
$1.63M Buy
89,537
+400
+0.4% +$8.16K 0.01% 451
2025
Q1
$1.77M Buy
+89,137
New +$1.54M 0.01% 400

Other funds holding ADMA

Virginia Retirement Systems's ADMA Position: Q2 2026 in Review

Virginia Retirement Systems reduced its ADMA Biologics (ADMA) stake by 5% in Q2 2026, selling an estimated $42.8K and leaving 89,337 shares worth $748K. The position accounts for ﹤0.01% of the portfolio, ranked #841.

Virginia Retirement Systems first reported a position in ADMA in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.77M in Q1 2025. 323 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Virginia Retirement Systems held 89,337 shares of ADMA Biologics worth $748K as of Q2 2026.
  • Virginia Retirement Systems sold 4,700 ADMA Biologics shares in Q2 2026, an estimated $42.8K.
  • ADMA Biologics made up ﹤0.01% of Virginia Retirement Systems's portfolio in Q2 2026, its #841 holding.
  • Virginia Retirement Systems first reported a position in ADMA Biologics in Q1 2025 and has held it in 6 quarters since.
  • Virginia Retirement Systems's ADMA Biologics position peaked at $1.77M in Q1 2025.
  • 323 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Virginia Retirement Systems's 13F filing for Q2 2026, filed 25 Aug 2026.